UK’s NHS Launches AI Regulation Service Specifically For Medtech Firms
Executive Summary
The regulatory landscape for digital and AI-based products can be tough for companies and users alike to navigate. Four UK organizations have partnered up to create a service that aims to demystify complex regulatory rules around AI and digital medtech.
You may also be interested in...
Companies Must Establish A ‘Realistic Value Proposition’ For AI Products, NICE Says
Manufacturers of innovative medtech products are more likely to achieve market access in the UK by determining where their product offers the most value to the health system before embarking on evidence generation, a senior figure at NICE has said.
UK £21m Funding To Boost AI Diagnostics Uptake In Hospitals
The UK government has set aside £21 million ($27m) to fund the uptake of artificial intelligence-based medtech tools that can be used to diagnose and treat patients faster in hospitals.
What The UK’s “Non-Statutory” AI Regulatory Framework Means For Medtech
The UK government has proposed a “pro-innovation” AI regulation strategy, which will utilize the expertise of existing regulators and avoid new legislation. But what does this mean for the medtech sector, and how does the UK approach differ from the EU’s AI Act?